Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, pharmacokinetics, and anti-tumor activity of GDC-1971 in combination with atezolizumab in locally advanced or metastatic solid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Atezolizumab (atezolizumab)
• GDC-1971

Snippet

Sponsor: Genentech, Inc. | Conditions: Advanced Solid Tumors, Metastatic Solid Tumors | Phase 1 | Status: COMPLETED